Google co-founder Sergey Brin’s foundation backed a major Parkinson’s study; in 2023, researchers validated a test that could detect disease-linked biology before movement symptoms appeared
The Sergey Brin Family Foundation, a private philanthropic organisation established in 2014 by Google co-founder Sergey Brin, supports a variety of important issues. These include research to understand, treat and improve the lives of people with central nervous system conditions and accelerating next-generation energy innovation. The foundation has also backed researchers who are running the Parkinson’s Progression Markers Initiative (PPMI) and achieved a major scientific milestone in 2023 by validating a biological test capable of spotting Parkinson’s pathology in living patients before physical symptoms surface.
The diagnostic breakthrough, detailed in a study published in The Lancet Neurology, centers on an assay known as αSyn-SAA (alpha-synuclein seed amplification assay).
